All of these results provide the strong supporting evidence that JT003 improves lipid metabolism in NASH mice through increasing of AMPK and PPARα as well as the PI3K-Akt-PPARγ signal activity. The gene discussed is PPARG; the disease is metabolic dysfunction-associated steatohepatitis.